Research Articles

View some of the latest research and breakthroughs articles for corneal dystrophy.

DMEK, DSO, and Gold Standards

Skip Atkins, Mentor, Fuchs Friends

In the title of her article1 published in the journal Cornea in 2022, Dr. Kathryn Colby poses an important question regarding the contemporary and emerging treatment of Fuchs Endothelial Corneal Dystrophy (FECD): “Descemet Stripping ...

The Future for the Care of Fuchs’ Dystrophy

Mark Gorovoy MD

Fuchs’ dystrophy is the most common diagnosis resulting in endothelial keratoplasty (EK), either DSAEK or DMEK, with the latter being an exact diseased tissue replacement These 2 procedures have been transformative, but progress ...

TTHX-1114: Engineered Endothelial Cell Growth Factor

William B. Trattler, MD

TTHX-1114: Engineered Growth Factor Has Potential to Treat Corneal Endothelial DeficienciesThe current standard of care for Fuchs and corneal endothelial dystrophies focuses on increasing the number and function of corneal ...

Covid-19 and Corneal Transplant Recipients

Christopher Sales, MD, MPH

Here’s the take-home message: The average corneal transplant recipient is not at increased risk for contracting COVID-19 because of their corneal transplants’ steroid eye drops. Let me walk you through why. There are 3 issues to ...

An Introduction to Fuchs’ Dystrophy for Patients

Christopher Sales, MD, MPH

Preface:I wrote the original draft of this to help my patients with Fuchs’ Endothelial Dystrophy better understand their disease and their therapeutic options. In 2018, one of my patients asked whether I’d be willing to publish it ...

High-Order Aberrations and Corneal Dystrophies

Sanjay V. Patel, MD FRCOphth

You might have heard the terms “aberrations” or “high-order aberrations”, but what are they, and do you need to worry about them? Simply put, “aberrations” are the different types of refractive error that an individual might have. ...

Dry Eye

Yuri McKee, MD

What we typically call “Dry Eyes” is really more accurately described as “Dysfunctional Tear Film”. People with this condition may have no symptoms at all or may experience a variety of conditions which may give us irritated, dry ...

Bob Bellizzi and Dorothy Acton were Godsends when I was diagnosed with Fuchs in the early 2000s and a full corneal transplant was the standard of care.
What a difference Bob made! He was a force of nature, and it is because of him and his legacy, the CDF, that we have so many more options and outstanding surgeons.  We have come from being told that we will go blind if we have Fuchs’ Dystrophy to DSEKs, DMEKs and DSOs.  I worked a couple of conferences with Bob and had many conversations with him when I was facilitating the NoVa/DC/Maryland Local Group.  I would like to say to Monica and the family on behalf of all of us, that Bob will be truly missed, and his legacy and leadership will live on.  Well done, Bob!

Left DSEK, 8-2005, Dr. Price Right DMEK/Triple, 7-2014, Dr. Jun

Skip to content